Duty free R&D import entitlement for pharma and biotech units upon regional certification of export performance and R&D registration. Permits duty free import entitlement for pharma and biotechnology units for R&D up to one percent of the preceding year's FOB exports where the unit's R&D wing is registered with the competent scientific authority and export thresholds are met. Regional Licensing Authorities may issue certification on formal application with prescribed appendices; applicants must submit a declaration that imports are solely for R&D, will be installed within six months, not transferred or sold for seven years, and a chartered accountant's certificate. The Regional Office verifies records and issues the certificate subject to notification conditions and penal consequences for false information.